CONMED Corporation (CNMD)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the data provided, CONMED Corporation's Days Sales Outstanding (DSO) is not available for the specified periods from March 31, 2020 to December 31, 2024. DSO is a key metric that indicates the average number of days it takes for a company to collect payments after making a sale.
Given that the DSO figures are not provided in the dataset, it is challenging to assess CONMED's efficiency in collecting accounts receivable or their credit policies' effectiveness. Monitoring DSO over time can help in evaluating the company's liquidity, cash flow management, and potentially identifying any issues related to customer credit or collections processes.
Therefore, without specific DSO data points for CONMED Corporation, it is not possible to conduct a detailed analysis or draw any conclusions regarding the company's accounts receivable management efficiency.
Peer comparison
Dec 31, 2024